000
| 01744cam 2200397zi 4500 |
---|
001 | 9.898938 |
---|
003 | CaOODSP |
---|
005 | 20221107174959 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 210420e20220210onc ob f000 0 eng d |
---|
020 | |a9780660385310 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH139-24/2021E-PDF |
---|
245 | 00|aGood manufacturing practices for active pharmaceutical ingredients. |
---|
246 | 17|aGood manufacturing practices for active pharmaceutical ingredients, version 2 (GUI-0104) |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cFebruary 10, 2022. |
---|
264 | 4|c©2021 |
---|
300 | |a1 online resource (127 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Bonnes pratiques de fabrication des ingrédients pharmaceutiques actifs. |
---|
500 | |a"GUI-0104." |
---|
500 | |a"Pub.: 210054." |
---|
500 | |aIssued also in HTML format. |
---|
504 | |aIncludes bibliographical references (pages 116-119). |
---|
650 | 0|aDrugs|xStandards|zCanada. |
---|
650 | 0|aDrug factories|zCanada. |
---|
650 | 0|aPharmaceutical industry|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tBonnes pratiques de fabrication des ingrédients pharmaceutiques actifs.|w(CaOODSP)9.898940 |
---|
856 | 40|qPDF|s2.19 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-24-2021-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidelines-active-pharmaceutical-ingredients-0104/document.html |
---|